News Articles

      • 30 April, 2018

    ISSCR 2018 to Highlight Research Driving New Discoveries and Advances in Regenerative Medicine

    Progress in stem cell research and its translation to medicine is the focus of the International Society for Stem Cell Research annual meeting 20-23 June at the Melbourne Convention & Exhibition Centre in Melbourne, Australia.
    Full story
      • 19 April, 2018

    ISSCR Advocates for Stem Cells and Basic Research in Europe

    ISSCR members and staff met 12 April with the European Parliament’s Committee on Industry, Research and Energy to advocate for investments in basic research in the European Union’s 9th Framework Programme for Research and Innovation.
    Full story
      • 9 April, 2018

    Collaborations for Improving Human Health

    Like many stem cell researchers, my work is increasingly focused on developing ways to translate basic scientific discovery into treatments that help people suffering from disease or injury. The potential for stem cell therapies initially fascinated me as a developmental biologist, and over time I’ve learned the very real impact that our science can have on human health.
    Full story
      • 3 April, 2018

    ISSCR Advocates for Science Investment in Letter to European Commission

    In a letter to the European Commission today, the ISSCR encourages the EU to spur innovation by supporting basic research and programs that foster cooperation among fundamental research endeavors across Europe.
    Full story
      • 14 March, 2018

    ISSCR Announces Recipients of 2018 Awards

    Recipients of the 2018 awards will be presented at the society’s annual meeting, 20-23 June in Melbourne, Australia: ISSCR Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award.
    Full story
      • 12 March, 2018

    'Right to Try' Legislation in U.S. House of Representatives is Narrowly Defeated; ISSCR Opposed

    The legislation would have put patients at risk, slowed the development of effective stem cell therapies, and blocked the Food and Drug Administration (FDA) from access to crucial data about the safety and effectiveness of new medical treatments.
    Full story
      • 12 March, 2018

    ISSCR 2018 Election Results

    The ISSCR is pleased to announce the results of its 2018 leadership election. On behalf of all members, we extend congratulations to newly-elected officers and board members.
    Full story
      • 12 March, 2018

    Scientific Excellence at ISSCR 2018

    Scientific excellence is at the core of the ISSCR and is reflected each year in the annual meeting, where exceptional science is shared, discussed, and deliberated. This exchange is key to advancing the scientific dialogue that moves the field forward. The 2018 program in Melbourne, Australia continues that tradition, featuring groundbreaking research presented in plenary, concurrent, and poster sessions.
    Full story
      • 15 February, 2018

    ISSCR Releases Guidebook to Evaluate Cell Therapy Trials

    The ISSCR is pleased to announce the release of “Stem Cell Based Clinical Trials: Practical Advice for Physicians and Ethics / Institutional Review Boards,“ a guidebook providing background and fundamental questions for clinicians and review boards to ask when considering running or reviewing early phase, cell-based clinical trials. The guide was developed by practicing physician-scientists and stem cell professionals on the ISSCR’s Clinical Translation Committee.
    Full story
      • 9 February, 2018

    Showcasing Inspiring Science and Natural Beauty

    There is no better host city for the ISSCR 2018 annual meeting than Melbourne, Australia, a global hub of innovation in science and biotech with a rich stem cell history, flourishing research culture, and inspiring natural beauty and art.
    Full story
      • 4 January, 2018

    ISSCR Remembers Hiromitsu “Hiro” Ogawa

    The ISSCR is saddened by the passing of Hiromitsu “Hiro” Ogawa, a generous and thoughtful man who was a great supporter of stem cell science and the ISSCR.
    Full story
      • 11 December, 2017

    ISSCR Announces New Policy Director, Eric Anthony

    The ISSCR has named Eric Anthony to be its new Director of Policy. Anthony served more than eight years as staff in the U.S. Congress, most recently as legislative director for Congresswoman Rosa DeLauro of Connecticut. He will join the Society in early January 2018.
    Full story
      • 8 December, 2017

    The ISSCR Remembers Ihor Lemischka

    The ISSCR joins the stem cell community in expressing sadness at the passing of Ihor Lemischka, PhD, Professor of Developmental and Regenerative Biology, Pharmacology and Systems Therapeutics at the Icahn School of Medicine.
    Full story
      • 6 December, 2017

    Message from the President: 2017 Year in Review

    The ISSCR celebrated its 15th year as a global voice for stem cell research, and our efforts and activities in 2017 reflect the key role the society plays in advancing the field. We advocated on behalf of members in the policy and regulatory arenas, provided resources for the public, and continued to provide a global forum for scientists to gather and share research.
    Full story
      • 17 November, 2017

    ISSCR Applauds the FDA Announcement of New Guidelines for Cellular Therapies and Cell-based Tissue Products

    The ISSCR commends the U.S. Food and Drug Administration (FDA) for reaffirming its regulatory authority over stem cell biologics and clarifying the criteria that determine which cell-based products fall under its oversight. These guidance documents will provide greater transparency for patients, medical professionals, and law enforcement authorities, about the legal status of stem cell treatments in the U.S.
    Full story